Clinical Trial Update: Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating induction of donor-specific tolerance in heart transplant recipients via donor stem cell infusion; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Snippet

Sponsor: Suzanne T. Ildstad | Conditions: Heart Transplantation | Phase 1, Phase 2 | Status: COMPLETED